Chemours Stock News

Chemours (CC) reported earnings 30 days ago. What's next for the stock?

WILMINGTON, Del.--(BUSINESS WIRE)---- $CC--Chemours Announces Dates for First Quarter 2024 Earnings Release and Webcast Conference Call.

From a technical perspective, Chemours (CC) is looking like an interesting pick, as it just reached a key level of support. CC recently overtook the 20-day moving average, and this suggests a short-te

From a technical perspective, Chemours (CC) is looking like an interesting pick, as it just reached a key level of support. CC recently overtook the 50-day moving average, and this suggests a short-te

Chemours Co (CC) Q4 2023 Earnings Call Transcript

Chemours (CC) fourth-quarter earnings beat estimates, while sales miss despite growth across TT and TSS segments.

Chemours beat estimates in the fourth quarter, but the news was overshadowed by an update on an ongoing probe into the company's accounting practices. Chemours is facing a challenging environment even

Shares in chemicals maker Chemours (CC) were down more than 8% in premarket trading Thursday morning as the disclosure of further details relating to an internal accounting probe and a soft current-qu

Chemours (CC) came out with quarterly earnings of $0.31 per share, beating the Zacks Consensus Estimate of $0.29 per share. This compares to break-even earnings per share a year ago.

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest

WILMINGTON, Del.--(BUSINESS WIRE)---- $CC--Chemours Announces Dates for Fourth Quarter 2023 Earnings Release, 2023 Form 10-K Filing and Webcast Conference Call.

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest

Chemours concluded an internal review it announced last week. The review found that three executives shifted the timing of payables and receivables to meet free cash flow targets and bolster their inc

Chemours delayed issuance of its financial reports for Q4 and 2023 this morning. Management warned that when it does report, it will report a loss.

The company's board has also placed both its CEO and CFO on administrative leave.